Search results
Increasing number of employers covering GLP-1 drugs for weight loss, survey finds
BenefitsPRO· 1 day agoInsurer resistance to covering the drugs is a limiting factor for sales growth for drugmakers,...
UroGen Pharma (NASDAQ:URGN) Price Target Raised to $53.50
ETF DAILY NEWS· 9 hours agoUroGen Pharma (NASDAQ:URGN – Free Report) had its price target hoisted by LADENBURG THALM/SH SH from $48.00 to $53.50 in a report published on Friday, Benzinga reports. They ...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
Los Angeles Times· 3 days agoOzempic, Wegovy and other new weight-loss drugs have proved so good at helping users shed pounds,...
Alchem Hit by EU Complaint Over Alleged Stomach Drug Cartel
Bloomberg· 2 days agoAlchem International has been hit with a formal antitrust complaint for allegedly plotting with rivals to fix prices of a key ingredient in drugs used for stomach complaints.
Biden Plan to Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say
North Denver News· 4 days agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients, independent pharmacists say they’re struggling to afford to keep some prescription ...
Access to Canadian drugs, state budget highlights and the truth behind '40 Acres and a Mule'
WLRN Miami· 23 hours agoEarlier this year, Florida became the first in the nation to receive authorization from the FDA to import certain prescription drugs from Canada. A company contracted by the state built a massive ...
Michigan’s largest insurer to drop weight-loss drug coverage - Indianapolis Business Journal
Indianapolis Business Journal· 3 days agoWeight-loss drugs from Novo Nordisk A/S and Indianapolis-based Eli Lilly and Co. will lose coverage...
2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80% | The Motley Fool
The Motley Fool· 3 hours agoHere's how high they could go, according to Wall Street, and whether these are slam-dunk buys for...
Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.
Barrons.com· 22 hours agoGilead Sciences stock was climbing Friday on hopes that it would get into the obesity-drug game....
Medicare sets $950 price for Renalytix kidney test By Investing.com
Investing.com· 1 day agoThis coverage aligns with the U.S. Food and Drug Administration's label for kidneyintelX.dkd and...